Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors


NCT00777504

Interventional

Phase 4

Unknown status
The purpose of this study is to determine if and how often an unexpected fast increase of disease and complaints shows after stopping the anti-angiogenetic therapy
More informations
Oct 31,2008
All
18 Years
N/A
30